Authors

• Takako Taniguchi (ORCID: https://orcid.org/0000-0002-3289-1077)
• Motosumi Nakagawa
• Jumpei Teramachi (ORCID: https://orcid.org/0000-0001-8722-5488)
• Takeshi Y. Hiyama (ORCID: https://orcid.org/0000-0001-8612-8707)
• Ariunzaya Bat‐Erdene (ORCID: https://orcid.org/0000-0003-1852-0584)
• Go Nishino
• Takeshi Harada (ORCID: https://orcid.org/0000-0002-3997-7471)
• Yoshio Katayama
• Eiji Tanaka (ORCID: https://orcid.org/0000-0002-2707-1613)
• Tatsuya Tominaga (ORCID: https://orcid.org/0000-0001-9985-6113)
• Masahiro Hiasa (ORCID: https://orcid.org/0000-0002-4830-6274)
• Asuka Oda
• Hisaaki Taniguchi
• Ken-ichi Matsuoka
• Sooha Matsuki
• Masahiro Abe
• Mariko Hanawa

Institutions

• Okayama University (JP)
• Mongolian National University (MN)
• Kobe University Hospital (JP)
• Mongolian National University of Medical Sciences (MN)
• Tokushima University Hospital (JP)
• Tokushima Hospital (JP)
• Tottori University (JP)
• Tokushima University (JP)

Publication Details

Journal

Haematologica

Published

2026-02-26

DOI

https://doi.org/10.3324/haematol.2025.300309

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Sanofi
• Japan Agency for Medical Research and Development
• Japan Society for the Promotion of Science
• Daiichi Sankyo Company
• Core Research for Evolutional Science and Technology
• Daiichi Sankyo Europe